Literature DB >> 1836311

Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts.

A Mitani1, K Kinoshita, K Fukamachi, M Sakamoto, K Kurisu, Y Tsuruhara, F Fukumura, A Nakashima, K Tokunaga.   

Abstract

We examined influences of a blocker (glibenclamide) and an opener (nicorandil) of the ATP-sensitive potassium (KATP) channel on extracellular K concentration [( K+]e), as well as the myocardial function and metabolites during global ischemia and reperfusion in Langendorff-perfused rat heart preparation. In control hearts, [K+]e began to rise 20 s after the onset of ischemia up to an initial peak (8.3 +/- 0.3 mM) at 2.5 +/- 0.7 min, then fell to 6.0 +/- 0.8 mM after 8.2 +/- 0.7 min, and then rose progressively to 14.6 +/- 0.8 mM at the end of 30 min of ischemia. Glibenclamide (50 microM) reduced the initial peak of [K+]e to 7.2 +/- 0.3 mM (P less than 0.01), and nicorandil (200 microM) increased it to 9.4 +/- 0.6 mM (P less than 0.01). There were no significant differences in [K+]e values among all groups at the end of ischemia. During ischemia, nicorandil decreased the time to mechanical arrest from 1.9 +/- 0.1 min to 1.5 +/- 0.1 min, whereas it was increased by glibenclamide to 2.7 +/- 0.4 min. In control hearts, the time to onset of ischemic contracture was 14.7 +/- 1.8 min. Nicorandil delayed onset of contracture and glibenclamide accelerated it. Thus we have confirmed that some part of the early increase in [K+]e during ischemia is attributable to K+ efflux through the KATP channel in our model, and opening of the KATP channel may contribute to a rapid reduction of the contractility of the ischemic myocardium that subsequently protects the myocardium against further ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836311     DOI: 10.1152/ajpheart.1991.261.6.H1864

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 2.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

3.  Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.

Authors:  J Munch-Ellingsen; E Bugge; K Ytrehus
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

4.  Effect of the potassium-channel opener nicorandil as an adjunct to cardioplegia on myocardial preservation in isolated rabbit hearts.

Authors:  Y Wang; M Sunamori; T Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Comparative effects of calcium and potassium channel modulators on ischemia/reperfusion injury in the isolated rat heart.

Authors:  Nina Simonovic; Vladimir Jakovljevic; Jovana Jeremic; Zarko Finderle; Ivan Srejovic; Tamara Nikolic Turnic; Isidora Milosavljevic; Vladimir Zivkovic
Journal:  Mol Cell Biochem       Date:  2018-06-19       Impact factor: 3.396

6.  Postrevascularization recovery of fatty acid utilization in ischemic myocardium: a randomized clinical trial of potassium channel opener.

Authors:  Y Kuwabara; S Watanabe; J Nakaya; R Hasegawa; K Matsuno; T Kuroda; Y Mikami; K Fujii; A Miyazaki; T Saito; Y Masuda
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

7.  Role of high-energy phosphate metabolism in hydrogen peroxide-induced cardiac dysfunction.

Authors:  Y Matsumoto; M Kaneko; M Iimuro; Y Fujise; H Hayashi
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 8.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 9.  Modulation of ischemia by regulation of the ATP-sensitive potassium channel.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

Review 10.  Role of ATP-sensitive K+ channel current in ischemic arrhythmias.

Authors:  A A Wilde
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.